Introduction
First week of life is a molding period in neonates, especially premature babies. Iatrogenic intrauterine growth restriction (IUGR) in neonatal intensive care unit (NICU) has been a prevailing problem in these days when smaller and smaller babies are being salvaged. Early aggressive total parenteral nutrition (PN) is defined when total of 4g/kg/day of amino acid is administrated via standardized PN to neonates over first week of life. Aggressive nutrition and optimal energy intake has a positive impact on growth [1, 2] , pulmonary morbidity, reduces risk of necrotizing enterocolitis and decreases hospital stay [3] . PN should therefore be started as soon as possible to achieve glucose level and enhance positive protein accretion. Increased protein intake at first week of life is also associated with improved neurodevelopmental outcome. [4] However, nutritional regimens to achieve these goal have not been fully understood, thus the varying parental nutrition formularies. Intrauterine protein accretion rate occur at 2 g/kg/day until 32 weeks of life and followed by 1.8 g/kg/day thereafter. However, if preterm infants were only given glucose, they will lose more than 1% of total protein stores each day. In a premature infant, optimal growth is achieved by a protein intake of 3.5 g/kg/day (0.56 g/kg/day of nitrogen). Studies have shown that protein intake as high as 4 g/kg/day are safe. [3] Generally, PN is gradually advanced within 1 to 2 weeks of life due to fear of intolerance attributed by immature metabolic pathways and ill state of premature newborns. There were concerns of uremia and metabolic acidosis if amino acid load were increased too aggressive in these infants.
The objective of our study is to promote growth without causing metabolic derangement in extremely preterm and extremely low birth weight infants via PN. There are 5 different PN regimens to fulfill nutritional requirement of infants. Started PN regimen provides amino acids of 2 g/kg/day at 60 ml/kg/day at 24 hours of life. It contains minimum amount of sodium and no potassium.
Standard preterm PN regimen provides 13.5 g/kg/day of glucose and 4 g/kg/day of amino acid when it runs at maximum of 135 mL/kg/day. Electrolytes and essential trace elements are formulated as per recommendation of European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPHAN) and American Academy of Paediatrics (AAP). [5, 6] Term PN regimen is designed for term infants with amino acid of 3 g/kg/day. 7.5% of dextrose PN regimen and high sodium PN regimen are designed to cater for hyperglycemia and hyponatremia in infants respectively. PN regimens are designed at 135 ml/kg/day and lipid emulsion at 3 g/kg/day (15 ml/kg/day) meets the parenteral nutrient and energy requirement, both protein and non protein energy, of the infant. 
METHODS

Study design
We performed a prospective study in NICU, in Sarawak General Hospital (SGH), from April 2013 to September 2013. Consent was taken from parents for insertion of umbilical venous catheter (UVC) for administration of PN.
Subjects
All newborns who admitted to NICU, SGH, with a gestation age of ≤ 32 weeks and/ or ≤ 1500g, or preterm infants with gestation age of > 32 weeks or > 1500g, or term infants, who is anticipated that enteral feeding of at least 120 ml/kg/day is unable to be established by day 5 and day 7 of life respectively, with PN, are eligible for participation in the study. Exclusion criteria were the duration of PN therapy is less than 5 days.
All newborns received PN when keep nothing by mouth. Enteral nutrition, expressed breast milk (EBM), was slowly introduced to stable newborns according to unit's feeding protocol guideline, concurrent with PN therapy. PN are taken off once they achieved near full feeding of at least 120 ml/kg/day of enteral feeding.
Protocol
Eligible infants were commenced with PN within 24 hours of life, unless specified. UVC is inserted after consent by parents. Once UVC is inserted, PN will be connected straight by the medical personnel who had inserted the UVC, to ensure the sterility. Peripheral indwelling central catheter (PICC) will be inserted if UVC dislodged or not suitable for use. During the first 24 hours of life, all infants were commenced with starter PN regimen which does not contain any potassium in the bag. After 24 hours of life, either standard term regimen or standard preterm regimen was given according to their gestation age. All PN regimens had been formulated according to the recommendations of AAP and ESPGHAN and were prepared by qualified pharmacy team in aseptic compound.
Each PN bag lasts for 48 hours and glucose concentration of the standard PN can be varies, either 7.5% or 10%. However, generally 10% glucose PN was given, unless specified.
All recruited infants are subjected to blood taking on the first 3 days after initiation of PN then every alternate day, which corresponds to PN ordering day. Blood investigations that were monitored include full blood count, renal profile, liver profile, biochemical test, blood gas and sugar profile. Occipitofrontal head circumference (OFC) and body length of infants were taken twice per week. Daily weighing was done but only weekly weights were collected.
In the event of any signs of line sepsis, UVC will be removed and PN halted. Blood cultures were then taken both from UVC or PICC and peripherally to confirm site of sepsis.
The Statistical Package for Social Sciences (SPSS, Version 16) software was used for statistical analysis. Correlation between two categorical variables was assessed by correlation coefficient.
RESULT This is a prospective study which involving of 69 eligible infants. Demographic characteristic are displayed in Table 3 .
In our sample population, 97% were premature and among the premature infants, 38% were extremely low birth weight infants, 46% were very low birth weight infants and 13% were low birth weight infants. 5.8% of infants who started PN after 24 hours were not able to tolerate feeding as targeted. Starter PN bag is introduced to newborn infants at day 1 of PN therapy. Starter PN, with total fluid volume of 60 mL/kg/day is administrated to infants, which composes of 2 g/kg/day of amino acid; electrolytes are initiated at the minimum requirement of a newborn baby and potassium only initiated to infants at day 2 of life onwards, in view of their not well established renal function. Mild hypokalemia was noticed at day 2 of therapy; however, it resolved when standard preterm PN bag was initiated. Hypophosphatemia was noticed as well even though it is adequately supplemented with the dose recommended by AAP and ESPGHAN. [5, 6] Other serum electrolytes were maintained within normal range throughout the PN therapy.
In our sample population, all the indicators for safety measure were fall within normal range. Serum BUN concentrations and serum triglyceride concentrations were in increasing trend on the first 3 and 5 day of PN therapy but stabilized after that. Serum bilirubin and serum alkaline phosphatase are the indicators for cholestasis and PN is the common cause of that.
Figure displayed in Table 5 showed increasing trend of both indicators throughout PN days but were still maintained in normal range of pediatrics group. Correlation coefficient of -0.26 showed a negative correlation between serum urea concentration and birth weight (grams) with different gestation age groups, which displayed in Figure 1 . In our sample population, same amount of amino acid were supplied to all preterm infants. Extremely premature infants with extremely low birth weight had highest mean urea concentration if compared to moderate to late preterm infants. As reported, extremely low birth weight infants have highest growth rate. [7] Therefore, rising BUN values are not just a reflection of extremely low birth weight infant's intolerance to amino acid infusion but it reflects appropriate amino acid utilization for both energy and lean mass production.
[10] Another unusual phenomenon is arising when various clinical trials are supporting aggressive amino acid to premature infants. During our study period, we noticed that with higher amount of amino acid supply, the lower is the serum phosphate level, in all infants recruited. Correlation coefficient of -0.92 showed a perfect negative correlation between amounts of amino acid administrated and serum phosphate concentration. In Figure 3 , where all infants recruited are categorized under extremely preterm, with extremely low birth weight, very preterm with very low birth weight and moderate to late preterm with low birth weight, hypophosphatemia is found more prominent in extremely preterm infants with extremely low birth weight during highest amino acid supply than moderate to late preterm with low birth weight.In our PN regime, sodium acetate is added. Acetate content has been partially replacing the chloride in the PN bags to reduce hyperchloremic metabolic acidosis and improving serum bicarbonate. Metabolic acidosis is improved when acetate intake increases alongside with increasing total fluid intake. There are 12.9% of premature neonates did not regain birth weight after 7 days of PN therapy. As displayed in Table 8 J o u r n a l o f P e d i a t r i c S c i e n c e s 2015; 7; e242 
DISCUSSION
Recent data has been supporting the importance of early aggressive amino acid administration via PN to newborns. The major concerns about early and aggressive delivery of amino acid especially to ELBW infants are the development of azotemia, hyperammonemia and metabolic acidosis.
Various studies also showed that there was no correlation between serum blood urea nitrogen (BUN) and amino acid intake. Restricting amino acid load solely based on serum BUN is not warrant because BUN also represents the complex interaction of hydration, renal function, energy quality and quantity and degree of illness. Rising BUN values are, therefore, not just a reflection of the ELBW infant's intolerance to amino acid infusion. In addition, PN therapy started within 24 hours of life shown to have better weight gains in all infants.
Restriction of amino acid load not only affects anabolic reactions and also it influences velocity of growth in premature infants. In addition, studies have shown that blood urea concentration up to 14 mmol/L in premature infants who receiving PN is acceptable. [2] Serum BUN is high when there is high amino acid oxidation. A study by Ridout et.al (2005) showed that there was no correlation between high amino acid intake and urea in preterm infants, especially extremely low birth weight infants, but due to their high rate of protein breakdown. [9] Studies of fetal amino acid oxidation also suggest that higher BUN reflects appropriate amino acid utilization for both energy and lean mass production. [9, 10, 11] The mean weight gain of premature infants in our study population is 15.3 g/kg/day, at a rate similar to the intrauterine weight gain of 15 g/kg/day where as term infants had weight gain of 11 g/kg/day, at a rate higher than reported intrauterine growth of 10 g/kg/day at term. [15, 16] ELBW infants have highest growth rate if compared to VLBW infants and LBW infants. [17] In addition, our sample population had average weekly increment in length of 1.2 cm and OFC of 1 cm, which are corresponded to reported intrauterine and postnatal growth of 1 cm/week and 0.5-1 cm/week respectively. [19] Growth velocity plays a major role in development outcomes and as an indicator of well being of infants. Slowest rate of weight gain in ELBW infants has highest morbidity. [19] A recent study by Ehrenkranz et al. also found that growth velocity influences growth and neurodevelopemental outcomes. [19] As the rate of weight gain and OFC increased, the better the neurodevelopment and the least of neurodevelopmental impairment. [19] Another concern of providing PN therapy to premature infants, especially to extremely premature newborns is the incidence of metabolic acidosis. In our PN formulation, sodium acetate is added in to partially replace the chloride to reduce the severity of acidosis and hyperchloraemia. Furthermore, a study by te Braake et al. showed that no significant differences in degree of acidosis in infants who received aggressive amino acid nutrition. [20] Another issue is arising when practice of nurturing premature infants with high amino acid load to enhance anabolism and promote growth. Similar to our result, Francesco Bonsante and colleagues (2013) also found that incidence of hypophosphatemia is high with high amino acid supply via PN therapy.
[21] During our study, all premature infants were instituted with same amount of amino acid, however, the severity of hypophosphatemia is less in moderate to late preterm infants with low birth weight, where severe hypophosphatemia is found in extremely preterm infants with extremely low birth weight, as shown in Figure 2 . Phosphorus is a main component of Adenosine triphosphate (ATP), membrane phospholipids and nucleic acids. Furthermore, rapid cell growth can be achieved when sufficient amount of nitrogen, potassium and phosphorus is provided. Thus, with the aggressive amino acid supply to promote extrauterine growth to premature infants especially to extremely preterm infants whose growth rate is the highest among all premature infants, results in high metabolism of phosphorus and high uptake of phosphorus into cell, thus affects its plasma concentration.
[21] In addition, Mizumoto defined this phenomenon as re-feeding syndrome as nutrition is commenced after intense nutritional deprivation in intrauterine. [22] On the other hand, by extending PN hang time to 48 hours instead of 24 hours is associated with minimizing TPN related cost. The change of practice also resulted in yearly savings of RM 62556.60, exclusive of labor cost and nursing cost. Another concern about extending hang time is increase risk of line sepsis; however a study by Kiran Kumar Balegar V et al. had suggested that no increase in central line-associated blood stream infection (CLABSI) with longer hang time. [23] CONCLUSION This single center study has proven that PN therapy is relatively safe to infants. With the standardized PN, it achieved goal of postnatal growth velocity and body composition in premature infants. In addition, the serum concentration of phosphate needs to be closely monitored and the amount of phosphorus needs to be optimized as to reduce the severity of hypophosphatemia condition. This study also demonstrated that the current practice of extending hang time is financially beneficial to hospital and reduced TPN pharmacy and nursing workload.
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